Monitor for any upcoming corporate events (earnings, pipeline updates) that could explain the timing, but this cluster alone does not signal insider concern. No trade action warranted.
PTCT drugs
PTCT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 9 $89.55entry
- T+1 · 4mo ago −5.25%α −5.68% · $84.85
- T+5 · 4mo ago −12.32%α −12.19% · $78.52
- T+20 · 3mo ago −20.88%α −23.12% · $70.85
- T+60 · 7w ago −29.13%α −31.52% · $63.46
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two C-suite insiders (CTOO and EVP/CLO) sold a total of ~$2.6M in shares on July 6-7, 2026, predominantly tied to option exercises. The total value represents only ~0.036% of PTCT's $7.3B market cap, making this a routine liquidity-driven cluster. No bearish signal is warranted.
Key Financial Metrics
Key Facts
- Chief Technical Operations Officer Neil Gregory Almstead sold ~$2.19M in open-market shares (net of option exercises).
- EVP and CLO Mark Elliott Boulding sold ~$406K in open-market shares (net of option exercises).
- Total open-market sale value of ~$2.59M is only 0.036% of PTCT's market cap.
- All sales coincide with option exercises, consistent with typical tax/vesting-related liquidity planning.
Financial Impact
~$2.59M in insider sales, immaterial relative to $7.3B market cap
Risk Factors
- No material insider selling risk identified
- Routine option-exercise-related sales do not imply negative outlook
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PTCT-1783576913200 |
Track record
29 reports on PTCT
4 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +19.01% at T+60 after the Apr 28, 2026 report. 5 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.09 Now $60.97 −1.80% settles Nov 17
- Nov 16, 2026today 144 Neutral 2/10 Entry $62.10 Now $60.97 −1.82% settles Nov 17
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $63.45 Now $60.97 −3.91% settles Nov 17
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $64.14 to $64.91 Now $60.97 −4.94% ▲ +1.20% −0.12% vs SPY
- Nov 3, 202613d ago 8-K Neutral 3/10 Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
- Nov 3, 202613d ago Press Release Neutral 3/10 Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
- Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $68.12 to $68.97 Now $60.97 +10.50% ▼ −1.25% +0.40% vs SPY
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $59.97 to $60.88 Now $60.97 +1.67% ▲ +1.52% +2.00% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $63.02 to $64.46 Now $60.97 −3.25% ▲ +2.29% +2.67% vs SPY
- Oct 16, 20264w ago Insider Cluster Neutral 3/10 Entry $61.53 to $62.92 Now $60.97 −0.91% ▲ +2.26% +1.92% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers